| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.94▼ | 1.94▲ | 1.95▼ | 1.95▼ | 1.91▲ |
| MA10 | 1.95▼ | 1.96▼ | 1.97▼ | 2.01▼ | 2.05▼ |
| MA20 | 1.97▼ | 1.95▼ | 1.95▼ | 1.92▲ | 2.14▼ |
| MA50 | 1.97▼ | 2.01▼ | 2.00▼ | 2.06▼ | 3.13▼ |
| MA100 | 2.04▼ | 1.95▼ | 1.92▲ | 2.17▼ | 14.03▼ |
| MA200 | 1.95▼ | 1.98▼ | 2.08▼ | 2.49▼ | 42.24▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.000▼ | 0.000▼ | 0.009▲ | 0.130▲ |
| RSI | 45.836▼ | 46.459▼ | 46.459▼ | 46.873▼ | 38.499▼ |
| STOCH | 14.683▼ | 12.345▼ | 25.092 | 40.197 | 36.248 |
| WILL %R | -80.000▼ | -88.889▼ | -66.667 | -39.086 | -62.304 |
| CCI | -66.667 | -53.846 | -28.165 | -18.804 | -58.088 |
| CDL | $ALZN Doji Candlestick Pattern Detected | Set Alert |
|
Wednesday, November 19, 2025 05:00 AM
ATLANTA, Nov. 19, 2025 /PRNewswire/ -- Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...
|
|
Tuesday, November 18, 2025 11:30 PM
In collaboration with Massachusetts General Hospital as the clinical trial site, Alzamend is investigating the distinctive characteristics of AL001. Alzamend Neuro AL001 (LiProSal) is a novel, ...
|
|
Tuesday, November 18, 2025 04:00 PM
Alzamend Neuro, Inc. (NASDAQ: ALZN) on Wednesday announced the completion of the clinical portion of its first Phase 2 clinical study of AL001 in healthy human subjects. ALZN stock is racing ahead of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/03/26 | 1.95 | 1.96 | 1.925 | 1.94 | 20,785 |
| 05/03/26 | 1.98 | 2.0001 | 1.9141 | 1.95 | 39,766 |
| 04/03/26 | 1.89 | 2.06 | 1.87 | 1.98 | 40,066 |
| 03/03/26 | 1.98 | 1.98 | 1.88 | 1.88 | 39,512 |
| 02/03/26 | 1.95 | 2.03 | 1.93 | 2.01 | 38,307 |
| 27/02/26 | 2.06 | 2.08 | 1.97 | 2.01 | 51,004 |
| 26/02/26 | 2.13 | 2.171 | 2.04 | 2.08 | 48,900 |
| 25/02/26 | 2.055 | 2.17 | 2.055 | 2.12 | 42,564 |
| 24/02/26 | 2.04 | 2.13 | 2.03 | 2.09 | 56,378 |
| 23/02/26 | 1.99 | 2.047 | 1.95 | 2.03 | 37,972 |
|
|
||||
|
|
||||
|
|